FEATURES OF THE INTESTINAL MICROBIOME FORMATION AND THE LEVEL OF INTESTINAL INFLAMMATORY RESPONSE IN NEWBORNS
Abstract
Objectives. We aim to explore the relationship between the composition of the faecal bacterial flora and the level of faecal calprotectin (FC) in sequential assessments of healthy term newborns.
Methods. The study was conducted thrice during the second, third, and fifth weeks of life. Culture method was used to identify the composition of intestinal microbiome indicators. FC levels were measured using an enzyme-linked immunosorbent assay. Mixed-effects linear modelling were applied to test for associations between calprotectin and various clinically relevant covariates/factors.
Results. Thirty-two infants were studied. Levels of Bifidobacterium was for children two weeks old (mean, standard deviation) – 8.91±1.47 CFU/g, for three weeks old – 8.44±1.58 CFU/g and for five weeks old – 8.09±1.49 CFU/g and Lactobacilli number for two weeks old – 7.69±1.15 CFU/g was higher than for three weeks old – 7.13±1.45 CFU/g and for five weeks old – 6.75±1.87 CFU/g. Level of FC for two weeks old was 280.6±123.68 mg/l, for three weeks old – 195.3±115.5 mg/l and for five weeks old – 153.5±34.6 mg/l. FC decreased with time and was higher in the presence of colonisation with Bifidobacterium, Lactobacilli, E.coli, and Opportunistic/Conditional pathogens.
Conclusions. The number of Bifidobacterium and Lactobacilli decreased during the neonatal period. FC also decreased but was higher in newborns colonised with Bifidobacterium, Lactobacilli, E.coli, and Opportunistic/Conditional pathogens, which apparently reflected stabilised composition of the microbiome and associated change in inflammatory processes.
Downloads
References
Ronan V, Yeasin R, Claud EC. Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development. Gastroenterology. 2021 Jan;160(2):495-506. https://www.doi.org/10.1053/j.gastro.2020.08.065
Rougé C, Butel M-J, Piloquet H, Ferraris L, Legrand A, Vodovar M et al. Fecal Calprotectin Excretion in Preterm Infants during the Neonatal Period. PLoS One. 2010; 5(6): e11083. https://www.doi.org/10.1371/journal.pone.0011083
Park J S, Cho J Y et. al. Dynamic Changes of Fecal Calprotectin and Related Clinical Factors in Neonates. Front Pediatr. 2020; 8: 326. https://www.doi.org/10.3389/fped.2020.00326
Łoniewska B, Adamek K, Węgrzyn D, Kaczmarczyk M, Skonieczna-Żydecka K, Clark J, Adler G, Tousty J, Uzar I, Tousty P, Łoniewski I. Analysis of Faecal Zonulin and Calprotectin Concentrations in Healthy Children During the First Two Years of Life. An Observational Prospective Cohort Study. J Clin Med. 2020 Mar 12;9(3):777. https://www.doi.org/10.3390/jcm9030777
Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014 Nov 18;14:189. https://www.doi.org/10.1186/s12876-014-0189-7
Däbritz J, Musci J, Foell D. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol. 2014 Jan 14;20(2):363-75. https://www.doi.org/10.3748/wjg.v20.i2.363
Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridgeret S al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47:506–513. https://www.doi.org/10.1136/gut.47.4.506
Ayling R., Kok K. Fecal Calprotectin. Adv Clin Chem 2018;87:161-190. https://www.doi.org/10.1016/bs.acc.2018.07.005
Farghaly MAA, Ali MAM, Ramey S, Said W, Abdelkarem A, Collin M. Characteristics of fecal calprotectin as an early marker for suspected necrotizing enterocolitis in newborns exclusively fed maternal breast milk: a case-control study. Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):43-47. https://www.doi.org/10.1080/08998280.2023.2277580
Yoon JM, Park JY, Ko KO, Lim JW, Cheon EJ, Kim HJ. Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr. 2014 Aug;57(8):351-6. https://www.doi.org/10.3345/kjp.2014.57.8.351
Kaczmarczyk M, Löber U, Adamek K, Węgrzyn D, Skonieczna-Żydecka K, Malinowski D, Łoniewski I, Markó L, Ulas T, Forslund SK, Łoniewska B. The gut microbiota is associated with the small intestinal paracellular permeability and the development of the immune system in healthy children during the first two years of life. J Transl Med. 2021 Apr 28;19(1):177. https://www.doi.org/10.1186/s12967-021-02839-w
Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015 Sep;33(9):496-503. https://www.doi.org/10.1016/j.tibtech.2015.06.011
Henrick BM, Chew S, Casaburi G, Brown HK, Frese SA, Zhou Y, Underwood MA, Smilowitz JT. Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants. Pediatr Res. 2019 Dec;86(6):749-757 https://www.doi.org/10.1038/s41390-019-0533-2
Weström B, Arévalo Sureda E, Pierzynowska K, Pierzynowski SG, Pérez-Cano FJ. The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals. Front Immunol. 2020 Jun 9;11:1153. https://www.doi.org/10.3389/fimmu.2020.01153
Lisowska-Myjak B, Skarżyńska E, Żytyńska-Daniluk J. Calprotectin in Serially Collected Meconium Portions as a Biomarker for Intrauterine Fetal Environment. Fetal Diagn Ther. 2018;43(1):68-71. https://www.doi.org/10.1159/000472150
F, Ma J, Geng S, Wang J, Liu J, Zhang J, Sheng X. Fecal calprotectin concentrations in healthy children aged 1-18 months. PLoS One. 2015 Mar 5;10(3):e0119574. https://www.doi.org/10.1371/journal.pone.0119574
Velasco Rodríguez-Belvís M, Viada Bris JF, Plata Fernández C, García-Salido A, Asensio Antón J, Domínguez Ortega G, Muñoz Codoceo RA. Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age. Paediatr Child Health. 2020 Aug;25(5):286-292. https://www.doi.org/10.1093/pch/pxz070
M van de Guchte M, Mondot S, Doré J. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis. Gastroenterology. 2021 Dec;161(6):1969-1981.e12. https://doi.org/10.1053/j.gastro.2021.08.057
Willers M, Ulas T, Völlger L, et al.. S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants. Gastroenterology 2020;159:2130–45. https://www.doi.org/10.1053/j.gastro.2020.08.019
Bjorkstrom MV, Hall L, Soderlund S, Hakansson EG, Hakansson S, Domellöf M. Intestinal flora in very low-birth weight infants. Acta Paediatr.2009;98:1762–1767. https://www.doi.org/10.1111/j.1651-2227.2009.01471.x
Kim ES, Tarassishin L, Eisele C, Barre A, Nair N, Rendonet A al. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies. Gastroenterology. 2021;160(4):1118-1130.e3. https://www.doi.org/10.1053/j.gastro.2020.11.050
Cekovic J R., Prodanovic N S., Mijailovic S S. et al. The perinatal factors that influence the excretion of fecal calprotectin in premature-born children. Open Medicine. 2022;17(1):1275-1281. https://doi.org/10.1515/med-2022-0522
Koivusaari K, Niinistö S, Nevalainen J, Honkanen J, Ruohtula T, Koreasalo M, Ahonen S, Åkerlund M, Tapanainen H, Siljander H, Miettinen ME, Alatossava T, Ilonen J, Vaarala O, Knip M, Virtanen SM. Infant Feeding, Gut Permeability, and Gut Inflammation Markers. J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):822-829. https://www.doi.org/10.1097/MPG.0000000000003756

This work is licensed under a Creative Commons Attribution 4.0 International License.

























